The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association of cognitive performance and IL-6 levels in schizophrenia is influenced by age and antipsychotic treatment
Authors
Keywords
-
Journal
NORDIC JOURNAL OF PSYCHIATRY
Volume -, Issue -, Pages 1-7
Publisher
Informa UK Limited
Online
2019-11-19
DOI
10.1080/08039488.2019.1688389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: a meta-analysis
- (2018) Bruno Romeo et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Elevated levels of C-reactive protein and IL-6 among the antipsychotic medicating schizophrenia patients of Siliguri, West Bengal, India
- (2018) Jiwan Gurung et al. NORDIC JOURNAL OF PSYCHIATRY
- Inflammation in individuals with schizophrenia – Implications for neurocognition and daily function
- (2018) Sophia Kogan et al. BRAIN BEHAVIOR AND IMMUNITY
- Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis
- (2018) Farivar Fathian et al. ACTA NEUROPSYCHIATRICA
- A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia
- (2017) Ellen Kure Fischer et al. JOURNAL OF NEURAL TRANSMISSION
- Neurocognitive impairment in deficit and non-deficit schizophrenia: a meta-analysis
- (2017) E. Bora et al. PSYCHOLOGICAL MEDICINE
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia
- (2017) Serhat Ergün et al. Psychiatry and Clinical Psychopharmacology
- First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction
- (2017) Funda Orhan et al. SCHIZOPHRENIA RESEARCH
- Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study
- (2017) Brian J. Miller et al. SCHIZOPHRENIA RESEARCH
- Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review
- (2017) Błażej Misiak et al. SCHIZOPHRENIA RESEARCH
- The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis
- (2016) Erik Johnsen et al. BMC Psychiatry
- Interaction of BDNF with cytokines in chronic schizophrenia
- (2016) Xiang Yang Zhang et al. BRAIN BEHAVIOR AND IMMUNITY
- Repurposing Drugs for Cognition in Schizophrenia
- (2016) YS Yang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Chemokine gene variants in schizophrenia
- (2016) Selcuk Dasdemir et al. NORDIC JOURNAL OF PSYCHIATRY
- Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
- (2016) B. Cabrera et al. PSYCHOLOGICAL MEDICINE
- Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset
- (2016) Ewa Bulzacka et al. SCHIZOPHRENIA BULLETIN
- Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy
- (2016) Hikaru Hori et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
- (2015) GE Araújo et al. Clinics
- IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
- (2015) Hussein Kadhem Al-Hakeim et al. JOURNAL OF AFFECTIVE DISORDERS
- Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca’s area volume
- (2015) S G Fillman et al. MOLECULAR PSYCHIATRY
- Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls
- (2015) Sigrun Hope et al. SCHIZOPHRENIA RESEARCH
- Evidence for an Immune Role on Cognition in Schizophrenia: A Systematic Review
- (2014) Rafael Ribeiro-Santos et al. Current Neuropharmacology
- Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women’s Health and Aging Study II
- (2014) Priya Palta et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder
- (2014) Adam Wysokiński et al. NORDIC JOURNAL OF PSYCHIATRY
- Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
- (2014) Rachel Upthegrove et al. SCHIZOPHRENIA RESEARCH
- Pharmacotherapy of cognitive deficits in schizophrenia
- (2013) Lewis A. Opler et al. CNS SPECTRUMS
- Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder
- (2013) Daimei Sasayama et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Is T-helper type 2 shift schizophrenia-specific? Primary results from a comparison of related psychiatric disorders and healthy controls
- (2013) Sonnig Sue-Whei Chiang et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis
- (2013) Valérie Tourjman et al. SCHIZOPHRENIA RESEARCH
- Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes
- (2012) Mónica Martínez-Cengotitabengoa et al. SCHIZOPHRENIA RESEARCH
- Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
- (2011) Brian J. Miller et al. BIOLOGICAL PSYCHIATRY
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Systematic Evaluation of Rating Scales for Drug-Induced Parkinsonism and Recommendations for Future Research
- (2010) Wilma Knol et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Microglia activation in schizophrenia
- (2010) Thalia F. van der Doef et al. NEUROIMAGE
- Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
- (2009) Akira Monji et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Interleukin-6 Covaries Inversely with Hippocampal Grey Matter Volume in Middle-Aged Adults
- (2008) Anna L. Marsland et al. BIOLOGICAL PSYCHIATRY
- Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
- (2008) Bart N. van Berckel et al. BIOLOGICAL PSYCHIATRY
- Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem
- (2008) D. Dickinson et al. SCHIZOPHRENIA BULLETIN
- Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
- (2008) M KESHAVAN et al. SCHIZOPHRENIA RESEARCH
- Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
- (2007) Stéphane Potvin et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started